PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

04 Feb 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Nasopharangeal Cancer · Phase 2 · Enrollment 94 · Sponsor: Sun Yat-sen University

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 04 Feb 2026. The item focuses on PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC. Open the detail page to review the full original feed content.